| | |||||
| lung cancer | |||||
| 新闻 | |||||
| Roche receives USFDA approval for VENTANA MET (SP44) RxDx Assay as companion ... Lung cancer is often diagnosed at an advanced stage when treatment options are limited; median survival is less than one year. Approximately 85% of ...
| |||||
| 查看更多结果 | 修改此快讯 | |||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment